Preliminary dose-response experiments. by Noelia Torremadé (3687523)

Patterns of lifetime use of substances by gender. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

S1 Data - by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Factors associated with substance use. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Factors associated with personality traits. by Daniel Waiganjo Kinyanjui (15877725)

“…The lifetime prevalence of substance use was 41.5%, while that of alcohol use was 36%. For both, a higher mean neuroticism score [substance use- (AOR 1.05, 95%CI; 1, 1.10: p = 0.013); alcohol use- (AOR 1.04, 95%CI; 0.99, 1.09: p = 0.032)] showed increased odds of lifetime use, while a higher mean agreeableness score [substance use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.008); alcohol use- (AOR 0.99, 95%CI; 0.95, 1.02: p = 0.032)] showed decreased odds of lifetime use. …”

Tendency chart of monthly FVC mean. by Yichuan Zhang (2888345)

“…<div><p>The study on the spatial distribution and dynamic change in monthly Fractional Vegetation Cover (FVC) of parks provides a scientific basis for vegetation management and optimization in urban parks. …”

Fig 7 - by Finn Egil Skjeldestad (7821716)

Subjects:

Effects of specific anti-miRs for the five miRNAss on the IC50 of cisplatin (A) and paclitaxel (B) in Hec1A cells. by Taek Sang Lee (494682)

Ulk2 morphants have a decreased extension/retraction ratio. by Stacey Lee (647217)

Temporal distributions of inscriptions and occupations using uniform 50-years-long timeblocks. by Vojtěch Kaše (6156971)

AQP2 and p-AQP2 abundance. by Sophie Constantin Lütken (689916)

“…Both antibodies reveal specific 29 kDa and 35–50 kDa bands. Data are presented in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0116501#pone.0116501.t004" target="_blank">Table 4</a>. …”

AQP1 abundance. by Sophie Constantin Lütken (689916)

“…<i>A</i>) L-Sham was decreased vs. Sham and HF, as also presented in <i>B</i>) and <i>E</i>). …”

E2 decreased sGC α1 protein expression in a PI3k-dependent pathway involving non-nuclear ER but does not modify sGC β1 after 3 h of incubation. by Jimena P. Cabilla (336466)

Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A... by Cho-Hao Lee (4114723)

“…</p><p>Conclusions</p><p>The treatment success rate of MCFG is superior to that of triazoles for the prophylaxis and treatment of IFIs, and correction of the mean patient age demonstrates that efficacy increases as patient age decreases. …”

Competitive Volumetric Bar-Chart Chip with Real-Time Internal Control for Point-of-Care Diagnostics by Ying Li (38224)

Competitive Volumetric Bar-Chart Chip with Real-Time Internal Control for Point-of-Care Diagnostics by Ying Li (38224)

Competitive Volumetric Bar-Chart Chip with Real-Time Internal Control for Point-of-Care Diagnostics by Ying Li (38224)

Gsα subunit abundance. by Sophie Constantin Lütken (689916)

OPG147 has no effect on TBK1 or IRF3-mediated ISRE activation and HT-DNA-induced signaling. by Xue-Mei Yi (18851202)

Average time necessary to disperse 50% of the population introduced (half-life time) in experiments and theoretical simulations, according to the number of woodlice initially intro... by Pierre Broly (228993)